| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/19/2007 | WO2007043652A1 2-thienylurea derivative |
| 04/19/2007 | WO2007043641A1 Inhibitor of transplanted islet dysfunction in islet transplantation |
| 04/19/2007 | WO2007043638A1 Condensed heterocyclic compound |
| 04/19/2007 | WO2007043606A1 Antidiabetic agent comprising anionic polyamino acid-metal complex |
| 04/19/2007 | WO2007043433A1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043306A1 Agent for amelioration of insulin resistance |
| 04/19/2007 | WO2007043305A1 Agent for amelioration of insulin resistance |
| 04/19/2007 | WO2007043302A1 Agent for amelioration of insulin resistance |
| 04/19/2007 | WO2007043294A1 Visceral fat accumulation inhibitor |
| 04/19/2007 | WO2007042910A1 Imidazoles and their use as hmg-coa reductase inhibitors |
| 04/19/2007 | WO2007042835A1 Chewing gum |
| 04/19/2007 | WO2007042745A1 Chocolate based appetite suppressant |
| 04/19/2007 | WO2007042669A2 Derivatives of 4-amino-quinazoline, preparation method thereof and use of same in therapeutics |
| 04/19/2007 | WO2007042668A1 Derivatives of 1-amino-isoquinoline, preparation method thereof and use of same in therapeutics in the treatment of a dysfunction associated with mch receptor 1 |
| 04/19/2007 | WO2007042660A2 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof |
| 04/19/2007 | WO2007042524A2 Treating diabetes using inhibitors of il-1 |
| 04/19/2007 | WO2007042178A1 Diacyl indazol derivatives as lipase and phospholipase inhibitors |
| 04/19/2007 | WO2007041833A1 Combined use of dpp iv inhibitors and gastrin compounds |
| 04/19/2007 | WO2007041817A1 Tood composition, use of an effective amount of sugar and biopolymer, and product |
| 04/19/2007 | WO2007024535A3 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/19/2007 | WO2007024535A2 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 04/19/2007 | WO2007015069A3 Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions |
| 04/19/2007 | WO2007009704A3 Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| 04/19/2007 | WO2007009656A3 Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof |
| 04/19/2007 | WO2007006391A3 Cynara scolymus extracts, the use thereof ans formulations containing them |
| 04/19/2007 | WO2007005320A3 Methods of delivering corticotroph-derived glycoprotein hormone |
| 04/19/2007 | WO2006129859A3 Combinations of a squalene synthase inhibitor and a hmg-coa reductase inhibitor for treating hyperlipidemia |
| 04/19/2007 | WO2006116157A3 Dipeptidyl peptidase-iv inhibitors |
| 04/19/2007 | WO2006088972A3 Use of modulatirs of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism |
| 04/19/2007 | WO2006071740A3 5ht2c receptor modulator compositions and methods of use |
| 04/19/2007 | US20070088163 Modulators of calcitonin and amylin activity |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088059 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088017 Benzothiazole derivatives for the treatment of diabetes |
| 04/19/2007 | US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3 |
| 04/19/2007 | US20070087958 Compounds and compositions for delivering active agents |
| 04/19/2007 | US20070087037 Stimulation of cpt-1 as a means to reduce weight |
| 04/19/2007 | US20070086988 Reversibly immortalized human pancreatic islet cell line containing an hTERT gene and an SV40T gene each interposed between a pair of LoxP sequences, characterized in that it is capable of producing insulin and enhancing expression of insulin after excising the hTERT gene and the SV40T gene, NAKT-13 |
| 04/19/2007 | DE102005048897A1 Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen Diacylindazol derivatives as inhibitors of lipases and phospholipases |
| 04/19/2007 | CA2625819A1 Leucine rich composition |
| 04/19/2007 | CA2625773A1 Inhibition of interleukin-6 (il-6) receptor promotes pancreatic islet transplantation |
| 04/19/2007 | CA2625546A1 Diacyl indazol derivatives as lipase and phospholipase inhibitors |
| 04/19/2007 | CA2625150A1 Combined use of dpp-iv inhibitors and gastrin compounds |
| 04/19/2007 | CA2624909A1 Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease |
| 04/19/2007 | CA2624890A1 Probiotics to influence fat metabolism and obesity |
| 04/19/2007 | CA2624683A1 Modulators of atp-binding cassette transporters |
| 04/19/2007 | CA2623535A1 Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/18/2007 | EP1775297A2 Adenosine receptor antagonists and methods of making and using the same |
| 04/18/2007 | EP1774974A1 Use of hyperforin or St. John's Wort in the treatment and prevention of metabolic syndrome |
| 04/18/2007 | EP1774973A1 Leucine rich composition |
| 04/18/2007 | EP1774967A1 Solid oral dosage forms comprising valsartan |
| 04/18/2007 | EP1773867A2 Proteinaceous compounds and uses therefor |
| 04/18/2007 | EP1773833A2 Pyrrolo(oxo)quinolines as 5ht ligands |
| 04/18/2007 | EP1773829A1 Amino-tropane derivatives, preparation thereof and therapeutic use thereof |
| 04/18/2007 | EP1773816A2 Modulators of atp-binding cassette transporters |
| 04/18/2007 | EP1773811A1 A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarbox amide hemisuccinate salt |
| 04/18/2007 | EP1773800A1 D-glucopyranosyl phenyl-substituted cyclene, medicaments containing these compounds, their use, and method for the production thereof |
| 04/18/2007 | EP1773778A1 Method for the preparation of crystal forms of torsemide in a pure state |
| 04/18/2007 | EP1773768A2 Pyrrole derivatives as pharmaceutical agents |
| 04/18/2007 | EP1773449A1 The use of medicinal plants and extracts thereof with growth promoting activity in veterinary medicine and zootechnics |
| 04/18/2007 | EP1773357A2 Compositions and methods of use of dimer digallates |
| 04/18/2007 | EP1773356A2 Insulin secretion by anthocyanins and anthocyanidins |
| 04/18/2007 | EP1773347A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/18/2007 | EP1773335A2 Nanoparticle dispersion containing lactam compound |
| 04/18/2007 | EP1773312A1 Composition containing statins and omega-3 fatty acids |
| 04/18/2007 | EP1773308A1 Combination of bupropion and a second compound for affecting weight loss |
| 04/18/2007 | EP1592417B1 Combination of antidiabetic drugs |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1436257B1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/18/2007 | EP1361264B1 PRODUCTS CONTAINING G(b)-GLUCAN |
| 04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
| 04/18/2007 | EP1335976B1 Modifier of organelle metalbolism |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1326613B2 Use of substituted imidazo 1,2-a|pyridine-, imidazo ¬1,2-a|pyrimidine and imidazo ¬1,2-a|pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 04/18/2007 | EP1137408B1 Agent for lowering endothelin levels |
| 04/18/2007 | EP1017390B1 Coated tablet comprising nicotinic acid or a compound metabolized to nicotinic acid in an extended release form, and a coating containing an hmg-coa reductase inhibitor in an immediate release form |
| 04/18/2007 | CN1950389A Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 04/18/2007 | CN1950372A 咪唑并吡啶化合物 Imidazopyridine compound |
| 04/18/2007 | CN1950361A Pyrrole or imidazole amides for treating obesity |
| 04/18/2007 | CN1950331A Polymorphic forms of nateglinide |
| 04/18/2007 | CN1950078A Counteracting drug-induced obesity using glp-1 agonists |
| 04/18/2007 | CN1947794A Medicine composition contg. sulfonylurea compounds and phenoxy acid type compounds |
| 04/18/2007 | CN1947792A Method for preparing active protein composition type nano-selenium and its liquid phase storage tech. |
| 04/18/2007 | CN1947778A Hypoglycemic medicine preparation and its prepn. method |
| 04/18/2007 | CN1947777A Method for treating diabets by Fuling, wolfberry fruit and radix scrophulariae with producing saliva and slaking thirst function |
| 04/18/2007 | CN1947770A Medicinal composition with wt.-reducing function |
| 04/18/2007 | CN1947762A Medicated composition with wt.-reducing and hypolipidemic functions |
| 04/18/2007 | CN1947760A Medicine for treating hyperlipidemia and its prepn. method |
| 04/18/2007 | CN1947737A Application of psammophytes strawflower total saponin in medicine |
| 04/18/2007 | CN1947731A Pearl products |
| 04/18/2007 | CN1947725A Body wt.-reducing salt mud |
| 04/18/2007 | CN1947722A Blood sugar regulator used during user having meals and its prepn. method |
| 04/18/2007 | CN1947712A Nano-safflower uranidin injection prepn. and its prepn. method |
| 04/18/2007 | CN1947693A Method for producing black mud by using well mineral salt as raw material |
| 04/18/2007 | CN1947585A Wt.-loss type oral liquor contg. fruits and vegetables |